Skip to content
#gene editing Open access

Carboxymethyl Dextran Coated Iron Oxide Magnetic Nanoparticles as Vehicles for CRISPR Ribonucleoproteins

Oct 2026 · bioRxiv · 0 citations · 30 references
Biology

TL;DR

CMD-coated MNPs are establish CMD-coated MNPs as a versatile platform for the delivery of Cas9 and Cas12a RNPs and support further investigation of magnetic nanoparticle-mediated genome editing for inherited skin disorders.

Abstract

The efficient and safe intracellular delivery of CRISPR ribonucleoproteins (RNPs) remains a major challenge for the development of genome editing strategies. Magnetic iron oxide nanoparticles (MNPs) offer an attractive and biocompatible delivery platform. However, their use for the delivery of functional CRISPR RNPs remains comparatively underexplored. Here, we developed carboxymethyl dextran (CMD)-coated MNPs as non-viral carriers for Cas9 and Cas12a RNPs. Nanocomplexes were formed through electrostatic interactions, without the need for chemical coupling reagents or additional surface functionalization. Both RNPs efficiently associated with MNPs, and the resulting nanocomplexes exhibited stable physicochemical properties and retained their cargo in serum-supplemented culture medium for up to 24 hours. Cellular uptake was confirmed by microscopy, while biocompatibility assays revealed no overt cytotoxicity. Functional genome editing was demonstrated at reporter and endogenous gene loci in HEK-293T cells, as well as in primary human dermal fibroblasts. Finally, we explored the therapeutic potential of this platform for recessive dystrophic epidermolysis bullosa (RDEB) by targeting COL7A1 exon 80, with the aim of removing the prevalent c.6527insC mutation while preserving the reading frame. Cas9 RNP nanocomplexes enabled exon 80 deletion. These findings establish CMD-coated MNPs as a versatile platform for the delivery of Cas9 and Cas12a RNPs and support further investigation of magnetic nanoparticle-mediated genome editing for inherited skin disorders.

Read PDF

Similar papers

#gene editing Open access Oct 2026

Delivering the Undeliverable: Rational Engineering of Membrane-Based and Synthetic Nanoparticle Platforms

Delivering therapeutic macromolecules to defined cell populations in vivo remains a central unsolved problem in biomedicine. Proteins, nucleic acids and viral vectors are cleared by phagocytes, degraded by enzymes, blocked by endothelial and interstitial barriers, and trapped in acidifying endolysosomes. Pre-existing i...

Qiang-Bing Yang · 0 citations
Open access Oct 2026

LGA-PEI nanoparticles enable efficient nucleic acid delivery to primary murine T cells.

Non-viral engineering of primary T cells is constrained by low transfection efficiency and significant cargo-induced toxicity. This study evaluates a LGA-PEI (lactic-co-glycolic acid-modified polyethyleneimine) nanoparticle system designed to overcome the recalcitrance of murine T cells, particularly unstimulated, muri...

Priscila Tonon Baschirotto, Christian Marín-Müller, Randall Loaiza-Montoya · 0 citations
#gene editing Review Open access Oct 2026

Zein-based hybrid nanocarriers for non-viral gene delivery: A review.

Zein-based gene delivery remains preclinical and requires stronger mechanistic, cargo-specific and route-specific validation, and translational rationale for zein lies not in superior intrinsic transfection efficiency, but in route-specific protection, sustained release, hydrophobic drug co-loading and use as a biodegr...

Dua Alsinglawi, Enass Serry Moursy, Bilgesu Kasurka et al. · 0 citations
Open access 2027

Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 Components for Genome Editing.

This protocol describes a standardized microfluidic workflow for reproducible LNP formulation, providing practical guidance on lipid preparation, nanoparticle assembly, and quality control.

A. Olsen, Camilla Blunk Brandt, Rasmus Karred Larsen et al. · 0 citations
Open access Sep 2026

Delivery of Anticancer Gold-Dithiocarbamate via Thiolated Chitosan Nanoparticles

Thiolated chitosan nanoparticles are highlighted as a promising redox-responsive platform for delivering gold-based metallodrugs, expanding therapeutic strategies for the treatment of triple-negative breast cancer.

Maame Abena O. Afrifa, Jovita O. Daraezinwa, Samuel G. Awuah · 0 citations
Open access

CRISPR/Cas9 Delivery Using Extracellular Vesicles.

Extracellular vesicles (EVs), particles released from cells, have the potential to become an important in vivo delivery vehicle for CRISPR machinery. Unlike viral vectors such as Adeno-associated virus (AAV), EVs reduce risks associated with immunogenicity, long-term expression, and potential off-target effects. EVs ca...

Peter Pečan, Mateja Manček-Keber · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.